BioCentury
ARTICLE | Clinical News

Dasotraline: Phase II data

December 22, 2014 8:00 AM UTC

Sumitomo Dainippon’s Sunovion Pharmaceuticals Inc. subsidiary reported data from a double-blind, U.S. Phase II trial in 341 adults with ADHD showing that once-daily 8 mg dasotraline met the primary en...